Join the live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investo...
TrialSpark technology-first approach to bring new treatments onto the market
Time is crucial, as even a single day saved in the development of a new medication can have a significant impact on pati...
Kernel: the empowering DNA manipulation
A software tool named Kernel is being developed by ASIMOV to incorporate various features related to DNA manipulation. R...
Transforming Pathology with AI: PathAI’s precision solutions for enhanced diagnostics and healthcare
PathAI is revolutionizing the field of pathology by utilizing AI models to enhance the analysis of patient tissue sample...
SOPHiA GENETICS empowers hematologic cancer research at Centre Hospitalier De Bastia with Ai-Driven Platform
On July 2023, SOPHiA GENETICS, a leading data-driven medicine company, has announced that the Centre Hospitalier de Bast...
Genenta Science: Temferon™ for the treatment of glioblastoma
Genenta Science, a clinical-stage immuno-oncology company, has received Orphan Drug Designation (ODD) from the European ...